Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析

◆英語タイトル:Croma-Pharma GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011329
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise princess skincare serums and princess skincare masks. Croma Pharma offers princess lift products which include happy lift and PDO. It distributes its products in various countries through its own commercial sales organization and through strategic partnerships and distributors. The company operates through its subsidiaries in Belgium, Brazil, Canada, Germany, France, the Netherlands, Poland, Romania, Spain and the US. Croma Pharma is headquartered in Leobendorf, Austria.

Croma-Pharma GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Croma-Pharma GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Croma-Pharma GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Croma-Pharma GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Croma-Pharma GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Croma-Pharma GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Croma-Pharma GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Croma-Pharma Forms Joint Venture with Sihuan Pharma 10
Croma Pharma Enters Into Co-Marketing Agreement With Ruck Tmed 11
Asset Transactions 12
Valeant Europe Acquires Ophthalmology and Orthopedic Brands from Croma-Pharma 12
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 13
Acquisition 14
Valeant Pharma Acquires Croma-Pharma Polska And Croma Romania From Croma-Pharma 14
Croma-Pharma GmbH – Key Competitors 15
Croma-Pharma GmbH – Key Employees 16
Croma-Pharma GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Strategy And Business Planning 19
Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Croma-Pharma GmbH, Medical Equipment, Key Facts 2
Croma-Pharma GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Croma-Pharma GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Croma-Pharma GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Croma-Pharma GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Croma-Pharma GmbH, Deals By Market, 2011 to YTD 2017 8
Croma-Pharma GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Croma-Pharma Forms Joint Venture with Sihuan Pharma 10
Croma Pharma Enters Into Co-Marketing Agreement With Ruck Tmed 11
Valeant Europe Acquires Ophthalmology and Orthopedic Brands from Croma-Pharma 12
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 13
Valeant Pharma Acquires Croma-Pharma Polska And Croma Romania From Croma-Pharma 14
Croma-Pharma GmbH, Key Competitors 15
Croma-Pharma GmbH, Key Employees 16
Croma-Pharma GmbH, Subsidiaries 17

★海外企業調査レポート[Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crown Van Gelder N.V.
    Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report Summary Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Powell Industries Inc (POWL):企業の財務・戦略的SWOT分析
    Powell Industries Inc (POWL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cameron International Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Cameron International Corporation (Cameron), a subsidiary of Schlumberger Limited specializes in engineering, designing, and manufacturing flow and pressure control technologies for oil and gas industry. The company offers drilling systems, dryaccess deepwater production systems, safety syst …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • H3 Biomedicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary H3 Biomedicine Inc (H3 Biomedicine), a subsidiary of Eisai Co Ltd is a biopharmaceutical company that offers therapies. The company concentrates on discovery and early development of novel, targeted anti-cancer compounds. Its products include small-molecule drugs that are developed by utiliz …
  • Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-bindi …
  • General Electric Co (GE)-石油・ガス分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Reckitt Benckiser Group plc:企業の戦略・SWOT・財務情報
    Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report Summary Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Reed’s, Inc. (REED):企業の財務・戦略的SWOT分析
    Summary Reed's Inc (Reed) is manufacturer and distribution of non-alcoholic carbonated soft drinks, candies and beverages. The company's product portfolio include Reed's ginger brew, wellness ginger shots, zero sugar, and ginger candies It brews carbonated ginger in various flavors including extra g …
  • Oxford Immunotec Ltd-医療機器分野:企業M&A・提携分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) is a medical device company that develops and commercializes proprietary tests. The company provides international T cell measurement products including T-Cell Xtend and T-SPOT. Its T-SPOT.TB test diagnoses both latent TB infection and active disease b …
  • Amarantus Bioscience Holdings Inc (AMBS):企業の財務・戦略的SWOT分析
    Summary Amarantus Bioscience Holdings Inc (Amarantus), formerly Amarantus BioSciences Inc, is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company’s pipeline products comprise eltoprazine and mesencephalic-astrocyte-derived neurotrophic factor. …
  • Akorn Inc (AKRX):企業の財務・戦略的SWOT分析
    Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • University of Utah-製薬・医療分野:企業M&A・提携分析
    Summary University of Utah (University of Utah) is a research university that offers various undergraduate and postgraduate programs. The university offers educational programs in various fields such as architecture and planning, engineering, fine arts, health, humanities, law, medicine, business, d …
  • Sangamo Therapeutics Inc (SGMO)-製薬・医療分野:企業M&A・提携分析
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biopharmaceutical company which focuses on the research and development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation and therapeutic genome editing. The company is …
  • Lagerwey Wind BV-エネルギー分野:企業M&A・提携分析
    Summary Lagerwey Wind BV (Lagerwey) is an alternative energy company that design and manufacture of wind turbines. The company’s wind turbines include L82-2.0 MW, L93 1.5 MW, L93 2.6 MW, L100 1.5 MW, L100 2.5 MW, L100- NL and L132-3.8 MW. Its technologies comprise turbine modular set-up, Nacelle, ge …
  • Dairygold Co-operative Society Ltd:企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • AdAlta Ltd (1AD):製薬・医療:M&Aディール及び事業提携情報
    Summary AdAlta Ltd (AdAlta), formerly AdAlta Pty Ltd, is a biotechnology company that discovers and develops new class of protein therapeutics for wide range of human diseases. The company's lead i-body candidate, AD-114, is being developed for the treatment of idiopathic pulmonary fibrosis and othe …
  • Stanley Furniture Company, Inc. (STLY):企業の財務・戦略的SWOT分析
    Stanley Furniture Company, Inc. (STLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆